COMMUNIQUÉS West-GlobeNewswire

Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering

27/06/2024 - 14:36

CHATHAM, N.J., June 27, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biopharmaceutical company, today announced it has entered into a [...]

Gain Therapeutics Presents GT-02287 Data at Federation of European Neuroscience Societies (FENS) Forum 2024 Demonstrating Improvements in Cognitive Performance in a Preclinical Model of GBA1 Parkinson’s disease

27/06/2024 - 14:35

Data demonstrates improvement in cognitive function in GBA1 Parkinson’s disease model in addition to reversal of motor function deficits BETHESDA, Md., June 27, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: [...]

Oragenics Develops Automated Intranasal Device for Treating Concussed Patients

27/06/2024 - 14:30

The device is intended for initial treatment in the acute setting SARASOTA, Fla., June 27, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal [...]

CytoDyn Announces Start of Preclinical MASH Study, Results Expected in Fall 2024

27/06/2024 - 14:30

VANCOUVER, Washington, June 27, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple [...]

Femasys to Participate in European Society of Human Reproduction and Embryology 40th Annual Meeting in Amsterdam

27/06/2024 - 14:30

Leading women’s reproductive health conference directly follows the company’s EU CE Mark approval for four of its products ATLANTA, June 27, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical [...]

Kane Biotech Makes First Commercial Sale of revyve™ Antimicrobial Wound Gel to ProgenaCare Global

27/06/2024 - 14:30

Kane Also Signs Long-Term Manufacturing Agreement With Halo Pharma WINNIPEG, Manitoba, June 27, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has made [...]

Comedian and Actor Drew “Druski” Desbordes Joins Safety Shot as Their Newest Brand Ambassador

27/06/2024 - 14:30

Druski Joins the Company’s Impressive Portfolio of Creators and Celebrities to Boost Awareness of the Revolutionary Beverage with a Wide Range of Consumers JUPITER, FL, June 27, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc [...]

Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine)

26/06/2024 - 22:57

Ohtuvayre is indicated for the maintenance treatment of COPD allowing for broad use in COPD patients First inhaled COPD treatment providing bronchodilation and non-steroidal anti-inflammatory effects Conference call [...]

Oragenics, Inc. Announces Closing of Public Offering

26/06/2024 - 22:47

SARASOTA, Fla., June 26, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced [...]

Tonix Pharmaceuticals Announces Proposed Public Offering

26/06/2024 - 22:40

CHATHAM, N.J., June 26, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biopharmaceutical company, today announced that it intends to offer and [...]

Clover Health Regains Compliance with NASDAQ Minimum Bid Price Requirement

26/06/2024 - 22:15

FRANKLIN, Tenn., June 26, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to [...]

Neurona Therapeutics Appoints Dr. Nadia Agopyan as Senior Vice President of Regulatory Affairs

26/06/2024 - 22:05

SAN FRANCISCO, June 26, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics , a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the nervous system, today announced the appointment [...]

MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer

26/06/2024 - 22:01

MARIETTA, Ga., June 26, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the appointment of Kim Moller to Chief Commercial Officer. Ms. Moller has been serving as [...]

Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

26/06/2024 - 21:13

CHATHAM, N.J., June 26, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company, today announced that it has regained compliance [...]

Progyny, Inc. to Host 2024 Inaugural Investor Day

26/06/2024 - 19:42

NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that it will host its inaugural Investor Day [...]

Tevogen Bio Files Registration Statement for Previously Disclosed Securities; Does Not Relate to Any Previously Undisclosed New Issuances of Dilutive Securities

26/06/2024 - 18:46

This new registration statement does not relate to any previously undisclosed new issuances of dilutive securities. Includes issuance of shares underlying warrants originally issued in 2021, earnout shares previously [...]

SMISS Asia Pacific 2024 Congress and training program

26/06/2024 - 18:00

Press release Ecully, June 26, 2024 – 6 p.m. Hands-on surgical training in Hong Kong at the SMISS Asia Pacific 2024 Congress The Spineway Group, a specialist in innovative implants for the treatment of severe spine [...]

Congrès Asie Pacifique SMISS 2024 et programme de formation

26/06/2024 - 18:00

Communiqué de presse Ecully, le 26 juin 2024 – 18h Formations pratiques chirurgicales à Hong Kong lors du congrès SMISS Asia Pacific 2024 Le groupe Spineway spécialiste des implants innovants pour le traitement des [...]

Valneva Announces Successful Outcome of its Combined General Meeting and Appointment of a New Director to its Board

26/06/2024 - 17:45

Saint-Herblain (France), June 26, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Board of Directors were approved by the [...]